Vol. 35 No. Supp 5 (1996): Acta Oncologica

Articles

• Bisphosphonate Therapy in Metastatic Breast Cancer

  Carl Blomqvist, Inkeri Elomaa

  81-83

  Published: 1996-01-01

  • PDF

• Primary Systemic Treatment with Weekly Doxorubicin Monotherapy in Women with Locally Advanced Breast Cancer; Clinical Experience and Parameters Predicting Outcome

  Turid Aas, Stephanie Geisler, Trond Paulsen, Anne Lise Børresen-Dale, Jan Erik Varhaug, Per Eystein Loünning, Lars Andreas Akslen

  5-8

  Published: 1996-01-01

  • PDF

• Novel Endocrine Therapies in Breast Cancer

  J. G. M. Klijn, B. Setyono-Han, M. Bontenbal, C. Seynaeve, J. Foekens

  30-37

  Published: 1996-01-01

  • PDF

• Concurrent Tamoxifen (TAM) + Cyclophosphamide, Epirubicin, and Fluorouracil (CEF) Versus Tam + Delayed Cef After Six Months of Endocrine Therapy in Metastatic Breast Cancer a Randomized Trial from the Danish Breast Cancer Cooperative Group (DBCG)

  P. Pfeiffer, C. Rose, B. Ejlertsen, M. Andersson, D. Pedersen, H. T. Mouridsen

  57

  Published: 1996-01-01

  • PDF

• Second-Line Endocrine Treatment of Advanced Breast Cancer—A Randomized Cross-Over Study of Medroxy-Progesterone Acetate and Aminoglutethimide

  R. Hultborn, I. Johansson-Terje, J. Bergh, U. Glas, L. Hallsten, T. Hatschek, E. Holmberg, K. Idestroüm, B. Norberg, J. Ranstam, M. Soüderberg, U-B. Wallgren

  75

  Published: 1996-01-01

  • PDF

• Overview on Human Breast Cancer with Focus on Prognostic and Predictive Factors with Special Attention on the Tumour Suppressor Gene P53

  T. Norberg, T. Jansson, S. Sjoügren, C. Mårtensson, I. Andréasson, M-L. Fjaüllskog, H. Lindman, H. Nordgren, A. Lindgren, L. Holmberg, J. Bergh

  96-102

  Published: 1996-01-01

  • PDF

• Insulin-Like Growth Factors in Breast Cancer

  Svein I. Helle, Per E. Lønning

  19-22

  Published: 1996-01-01

  • PDF

• Analgesic Effect of Bisphosphonates on Bone Pain in Breast Cancer Patients a Review Article

  Peter Strang

  50-54

  Published: 1996-01-01

  • PDF

• Endocrine Treatment of Advanced Breast Cancer

  Mitchell Dowsett

  68-72

  Published: 1996-01-01

  • PDF

• Predictive Factors for Response to Cytotoxic Treatment in Advanced Breast Cancer a Review

  Johanna Sjoüstroüm, Carl Blomqvist

  84-90

  Published: 1996-01-01

  • PDF

• Mechanisms of Tamoxifen Resistance in the Treatment of Advanced Breast Cancer

  Anne E. Lykkesfeldt

  9-14

  Published: 1996-01-01

  • PDF

• Aromatase Inhibition for Breast Cancer Treatment

  Per E. Loünning

  38-43

  Published: 1996-01-01

  • PDF

• Palliative Treatment of Bone Metastases

  Ole S. Nielsen

  58-60

  Published: 1996-01-01

  • PDF

• Chemotherapy Resistance Mechanisms

  Ulrik Ringborg, Anton Platz

  76-80

  Published: 1996-01-01

  • PDF

• Foreword

  Thomas Hatschek, Carl Blomqvist, Per E. Lønning, Carsten Rose

  3-4

  Published: 1996-01-01

  • PDF

• The Future of Bisphosphonates in Cancer

  Robert E. Coleman, O. P. Kash Purohit, Jeferson J. Vinholes

  23-29

  Published: 1996-01-01

  • PDF

• Bisphosphonate Therapy in Multiple Myeloma

  Markku Laakso, Esa Jantunen

  55-56

  Published: 1996-01-01

  • PDF

• Efficacy of Pamidronate in Breast Cancer with Bone Metastases: A Randomized Double-Blind Placebo Controlled Multicenter Study

  R. Hultborn, S. Gundersen, S. Rydén, E. Holmberg, J. Carstensen, U-B. Wallgren, S. Kilany

  73-74

  Published: 1996-01-01

  • PDF

• Endocrine Resistance in Advanced Breast Cancer

  Mitchell Dowsett

  91-95

  Published: 1996-01-01

  • PDF

• Letrozole (CGS 20267), A New Oral Aromatase Inhibitor for the Treatment of Advanced Breast Cancer in Postmenopausal Patients

  Patrick F. Trunet, Ajay S. Bhatnagar, Hilary A. Chaudri, Ulrike Hornberger

  15-18

  Published: 1996-01-01

  • PDF

• Proper Sequence of Endocrine Therapies in Advanced Breast Cancer

  Carsten Rose

  44-49

  Published: 1996-01-01

  • PDF

• Rationale for the Use of Bisphosphonates in Breast Cancer

  John A. Kanis

  61-67

  Published: 1996-01-01

  • PDF